ALLMedicine™ Allergic Bronchopulmonary Aspergillosis Center

Sep 11th, 2021 - Whether a combination of glucocorticoid and antifungal triazole is superior to glucocorticoid alone, in reducing exacerbations, in patients with allergic bronchopulmonary aspergillosis (ABPA) remains unknown. We aimed to compare the efficacy and s...

Aug 25th, 2021 - Allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis (CF) is frequently associated with significant structural lung damage as assessed by computed tomography (CT) scanning. Using a validated CF scoring system (structural lun...

Aug 20th, 2021 - Plastic bronchitis is a rare, underdiagnosed and potentially fatal condition. It is characterised by the formation and expectoration of branching gelatinous plugs that assume the shape of the airways. These airway plugs differ from the allergic mu...

Aug 9th, 2021 - Allergic bronchopulmonary aspergillosis (ABPA) is associated with frequent exacerbations and poor outcomes in chronic respiratory disease, but remains underdiagnosed. The role of fungal sensitization in bronchiectasis-COPD overlap (BCO) is unknown...

Jul 31st, 2021 - Aspergillus may cause different types of lung infections: invasive, chronic pulmonary or allergic bronchopulmonary aspergillosis. Pharmacological management with antifungals poses as a challenge. Patients diagnosed with pulmonary aspergillosis are...

Jun 4th, 2019 - Blood eosinophilia > 4% or 300-400 cells/μL supports the diagnosis of asthma, but the absence of this finding is not exclusionary. Total serum immunoglobulin E levels > 100 IU/mL are frequently observed in patients experiencing allergic reactions,...